Molecule Ventures LLP – Portfolio Management Services (PMS)

Molecule Ventures operates as a Portfolio Management Services (PMS) provider, duly registered with the Securities and Exchange Board of India (SEBI) as a Portfolio Manager. The core investment strategy of this fund is focused on achieving capital growth over a medium to long-term horizon. This is to be accomplished by strategically allocating capital towards high-quality companies exhibiting robust growth potential, with a predominant emphasis on the Mid and Small Cap segments of the equity market.

AUM (₹ Cr)

776.98

Clients

431

As On

30 November 2025

Portfolio Managers & Fund Management Team

Mr Nirav Parikh

Fund Manager

Mr. Nirav Parikh possesses extensive investment experience, spanning 16 years, with a particular focus on small and mid-cap companies. His prior professional engagements include roles at Ghalla Bhansali, Reliance Equities, and Alchemy Capital, where he gained exposure to diverse industry sectors. Academically, he holds an MBA from NMIMS, Mumbai, and a Bachelor's degree in Commerce from Mumbai University. Furthermore, he is a CFA Charterholder (US) and holds the FRM designation.

Interested in Molecule Ventures LLP?

Get in touch with our partner to learn more about Molecule Ventures LLP's portfolio management services and how they align with your investment goals.

Regulatory Information

SEBI Registration: INP000007216

Registered Office: Flat no 802, 8th floor, Kingston Tower , G D ambekar marg, parel, tank road,mumbai,maharashtra,india,400012

Disclaimer

This page is provided solely for general informational purposes in relation to the strategy and is based on publicly available information. While reasonable care has been taken to ensure accuracy, the information may not reflect the most recent updates.

Nothing on this page constitutes investment, financial, or legal advice, nor should it be considered a recommendation. Investment decisions should be made after consulting a qualified advisor and reviewing official scheme documents.

The individuals or organizations featured have not endorsed or approved this content. Affluense AI does not act as a broker, distributor, intermediary, or investment advisor.

For official or regulatory matters, please refer to formal communication channels of the respective organization.

Last Updated: December 2025 · Published by Affluense AI (affluense.ai)